Support program to improve quality of life for Chinese cancer patients and survivors
A Multicomponent Support Program to Enhance Quality of Life in Chinese Cancer Patients and Survivors (MSP-CCS): Pilot Optimization Trial and Implementation Outcomes
NA · Memorial Sloan Kettering Cancer Center · NCT07454330
This program will try different mixes of education, counseling, and peer support to see if they help Mandarin-speaking adults with cancer or who have finished treatment feel better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center (other) |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Trial ID | NCT07454330 on ClinicalTrials.gov |
What this trial studies
This interventional program tests combinations of cancer education sessions, meaning-centered counseling, peer support meetings, and enhanced standard care delivered largely via telehealth. Eligible participants are adults of Chinese descent who speak Mandarin, were diagnosed with cancer within the past five years, and report moderately low health-related quality of life (FACT-G <70). Sessions will be audio-recorded for fidelity, and participants with active suicidal risk are excluded and referred for higher-level care. The research team will track practicality (feasibility, engagement) and changes in quality of life over the intervention period.
Who should consider this trial
Good fit: Ideal candidates are Mandarin-speaking adults of Chinese descent living in New York or New Jersey who were diagnosed with cancer within the last five years and report moderately low quality of life and willingness to participate by telehealth.
Not a fit: Patients who cannot speak Mandarin well, live outside New York/New Jersey, are unwilling to use telehealth, or who have active suicidal risk requiring higher-level care are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could improve coping, social support, and overall quality of life for Mandarin-speaking cancer patients and survivors.
How similar studies have performed: Previous research has shown that education, meaning-centered counseling, and peer support can improve quality of life in cancer populations, but culturally tailored combinations for Mandarin-speaking Chinese patients are less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years * Age ≥ 18 years (per EMR for MSK patients or self-report for external participants) Self-Report Criteria: * Of Chinese descent * Speaks Mandarin "well" or "very well" * Moderately low HRQOL (\<70 FACT-G score)4, 48 * Resides in New York or New Jersey * Agrees to participate via telehealth (video or phone) * Agrees to be audio-recorded Exclusion Criteria: Self-Report Criteria: * Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of \> 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS) * Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?" * Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score \< 12) * Per consenting professional determination, unable to understand the informed consent procedure * Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients) * Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)
Where this trial is running
Basking Ridge, New Jersey and 6 other locations
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey, United States (RECRUITING)
- Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey, United States (RECRUITING)
- Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States (RECRUITING)
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities) — Commack, New York, United States (RECRUITING)
- Memorial Sloan Kettering Westchester (All Protocol Activities) — Harrison, New York, United States (RECRUITING)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (RECRUITING)
- Memorial Sloan Kettering Nassau (All Protocol Activities) — Uniondale, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Florence Lui, PhD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Florence Lui, PhD
- Email: luif@mskcc.org
- Phone: 646-888-8375
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Survivorship, Chinese, Quality of Life, Patients, Survivors, 26-025